Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02189850 · ClinicalTrials.gov registry record · Phase 2
Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy
A Phase 2 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 2
- Development phase
- 29
- Enrollment target
NCT02189850 is a Phase 2 study that has completed, run by Braintree Laboratories. The registered enrollment target is 29 participants.
The verdict
NCT02189850, a Phase 2 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 29 participants
- Enrollment target
Study Summary
The purpose o this study is to evaluate the safety, tolerance and efficacy of BLI800 as a bowel preparation prior to colonoscopy in pediatric patients.
Interventions
- DRUG BLI800 - Dose 1
- DRUG BLI800 - Dose 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02189850
The ClinicalTrials.gov registry entry for NCT02189850 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BLI800 - Dose 1 is the first listed.
NCT02189850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02189850 about?
NCT02189850 is a clinical study titled "Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy". The purpose o this study is to evaluate the safety, tolerance and efficacy of BLI800 as a bowel preparation prior to colonoscopy in pediatric patients.
What is the current status of trial NCT02189850?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 29 participants. The study started on 2014-06. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02189850?
The interventions under investigation include: BLI800 - Dose 1 (DRUG), BLI800 - Dose 2 (DRUG).
Who is sponsoring clinical trial NCT02189850?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.